Jiangsu Wuzhong Industrial Co Ltd - Asset Resilience Ratio
Jiangsu Wuzhong Industrial Co Ltd (600200) has an Asset Resilience Ratio of 1.08% as of December 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Jiangsu Wuzhong Industrial Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2020)
This chart shows how Jiangsu Wuzhong Industrial Co Ltd's Asset Resilience Ratio has changed over time. See Jiangsu Wuzhong Industrial Co Ltd net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Jiangsu Wuzhong Industrial Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600200 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥40.01 Million | 1.08% |
| Total Liquid Assets | CN¥40.01 Million | 1.08% |
Asset Resilience Insights
- Limited Liquidity: Jiangsu Wuzhong Industrial Co Ltd maintains only 1.08% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Jiangsu Wuzhong Industrial Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jiangsu Wuzhong Industrial Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 3.28% |
|
Ascendis Pharma AS
F:A71 |
Biotechnology | 0.00% |
|
Summit Therapeutics PLC
NASDAQ:SMMT |
Biotechnology | 0.00% |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278 |
Biotechnology | 4.69% |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076 |
Biotechnology | 1.39% |
|
Wuhan Keqian Biology Co Ltd
SHG:688526 |
Biotechnology | 19.42% |
|
R&G PharmaStudies Co. Ltd. A
SHE:301333 |
Biotechnology | 35.96% |
|
Shanghai Shen Lian Biomedical Corp
SHG:688098 |
Biotechnology | 3.87% |
Annual Asset Resilience Ratio for Jiangsu Wuzhong Industrial Co Ltd (2000–2020)
The table below shows the annual Asset Resilience Ratio data for Jiangsu Wuzhong Industrial Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 1.08% | CN¥40.01 Million ≈ $5.86 Million |
CN¥3.70 Billion ≈ $541.97 Million |
+0.05pp |
| 2019-12-31 | 1.03% | CN¥40.52 Million ≈ $5.93 Million |
CN¥3.92 Billion ≈ $573.61 Million |
+1.03pp |
| 2018-12-31 | 0.01% | CN¥240.60K ≈ $35.21K |
CN¥4.62 Billion ≈ $675.75 Million |
-0.01pp |
| 2017-12-31 | 0.02% | CN¥836.82K ≈ $122.45K |
CN¥4.63 Billion ≈ $678.18 Million |
+0.00pp |
| 2016-12-31 | 0.02% | CN¥813.08K ≈ $118.98K |
CN¥5.24 Billion ≈ $766.71 Million |
-0.01pp |
| 2015-12-31 | 0.03% | CN¥1.09 Million ≈ $159.93K |
CN¥4.24 Billion ≈ $620.80 Million |
-0.02pp |
| 2014-12-31 | 0.05% | CN¥1.85 Million ≈ $270.39K |
CN¥4.02 Billion ≈ $588.09 Million |
-0.11pp |
| 2013-12-31 | 0.15% | CN¥6.09 Million ≈ $890.55K |
CN¥3.93 Billion ≈ $575.14 Million |
-0.12pp |
| 2012-12-31 | 0.28% | CN¥12.03 Million ≈ $1.76 Million |
CN¥4.31 Billion ≈ $630.51 Million |
0.00pp |
| 2011-12-31 | 0.28% | CN¥10.68 Million ≈ $1.56 Million |
CN¥3.77 Billion ≈ $551.99 Million |
-0.14pp |
| 2010-12-31 | 0.42% | CN¥12.33 Million ≈ $1.80 Million |
CN¥2.95 Billion ≈ $430.99 Million |
+0.05pp |
| 2009-12-31 | 0.37% | CN¥7.46 Million ≈ $1.09 Million |
CN¥2.00 Billion ≈ $293.08 Million |
+0.34pp |
| 2008-12-31 | 0.04% | CN¥722.51K ≈ $105.73K |
CN¥2.03 Billion ≈ $297.48 Million |
-0.10pp |
| 2006-12-31 | 0.13% | CN¥3.00 Million ≈ $438.99K |
CN¥2.30 Billion ≈ $336.07 Million |
+0.00pp |
| 2005-12-31 | 0.13% | CN¥2.80 Million ≈ $409.73K |
CN¥2.21 Billion ≈ $323.34 Million |
+0.12pp |
| 2004-12-31 | 0.01% | CN¥178.40K ≈ $26.11K |
CN¥1.92 Billion ≈ $281.11 Million |
-1.66pp |
| 2003-12-31 | 1.67% | CN¥29.51 Million ≈ $4.32 Million |
CN¥1.77 Billion ≈ $258.37 Million |
+1.50pp |
| 2002-12-31 | 0.17% | CN¥2.14 Million ≈ $313.04K |
CN¥1.23 Billion ≈ $179.77 Million |
-4.14pp |
| 2000-12-31 | 4.32% | CN¥30.00 Million ≈ $4.39 Million |
CN¥695.18 Million ≈ $101.73 Million |
-- |
About Jiangsu Wuzhong Industrial Co Ltd
JiangSu WuZhong Pharmaceutical Development Co., Ltd. engages in pharmaceutical, medical cosmetology, investment, and other industries in China and internationally. It provides genetic and chemical drugs in the fields of anti-virus, anti infection, immune regulation, anti-tumor, digestive system, cardiovascular, etc.; and modern traditional Chinese medicine. The company also offers high-end inject… Read more